Literature DB >> 24786669

IFN-λ4: the paradoxical new member of the interferon lambda family.

Thomas R O'Brien1, Ludmila Prokunina-Olsson, Raymond P Donnelly.   

Abstract

Interferons (IFNs) are generally considered antiviral cytokines, yet the newly discovered IFN-λ4 is linked with the failure to clear hepatitis C virus (HCV) infection either spontaneously or in response to treatment. IFN-λ4 can be generated only by individuals who carry the IFNL4-ΔG allele (rs368234815), which is the strongest known host factor for predicting clearance of HCV. The ancestral IFNL4-ΔG allele is the major variant in Africans while the minor variant in Asians, suggesting very strong negative genetic selection for this allele-most likely driven by an infectious agent other than HCV. IFN-λ4 most closely resembles IFN-λ3, but these proteins share only 29% amino-acid identity, and, in contrast to IFN-λ3, IFN-λ4 is only weakly secreted. Nevertheless, IFN-λ4 signals through the IFN-λ receptor complex and induces expression of IFN-stimulated genes via the Janus kinase-signal transducer and activator of transcription signaling pathway. Although the IFNL4-ΔG variant is strongly associated with the failure to clear HCV infection, HCV-infected patients who carry this allele have lower baseline HCV RNA levels in the absence of treatment. Resolving the paradoxical functions of IFN-λ4, which appears to induce antiviral activity yet impair effective clearance of HCV, may yield critical new insights into the immunologic response to HCV infection and IFN biology.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24786669      PMCID: PMC4217005          DOI: 10.1089/jir.2013.0136

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  58 in total

1.  IL-28, IL-29 and their class II cytokine receptor IL-28R.

Authors:  Paul Sheppard; Wayne Kindsvogel; Wenfeng Xu; Katherine Henderson; Stacy Schlutsmeyer; Theodore E Whitmore; Rolf Kuestner; Ursula Garrigues; Carl Birks; Jenny Roraback; Craig Ostrander; Dennis Dong; Jinu Shin; Scott Presnell; Brian Fox; Betty Haldeman; Emily Cooper; David Taft; Teresa Gilbert; Francis J Grant; Monica Tackett; William Krivan; Gary McKnight; Chris Clegg; Don Foster; Kevin M Klucher
Journal:  Nat Immunol       Date:  2002-12-02       Impact factor: 25.606

2.  New genetic discoveries and treatment for hepatitis C.

Authors:  Michael Pacanowski; Shashi Amur; Issam Zineh
Journal:  JAMA       Date:  2012-05-09       Impact factor: 56.272

3.  One more piece in the interleukin 28B gene puzzle? The case of hepatitis B.

Authors:  Nikolaus Jilg; Raymond T Chung
Journal:  Hepatology       Date:  2013-03       Impact factor: 17.425

4.  A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus.

Authors:  Ludmila Prokunina-Olsson; Brian Muchmore; Wei Tang; Ruth M Pfeiffer; Heiyoung Park; Harold Dickensheets; Dianna Hergott; Patricia Porter-Gill; Adam Mumy; Indu Kohaar; Sabrina Chen; Nathan Brand; McAnthony Tarway; Luyang Liu; Faruk Sheikh; Jacquie Astemborski; Herbert L Bonkovsky; Brian R Edlin; Charles D Howell; Timothy R Morgan; David L Thomas; Barbara Rehermann; Raymond P Donnelly; Thomas R O'Brien
Journal:  Nat Genet       Date:  2013-01-06       Impact factor: 38.330

5.  Biological activity of interleukins-28 and -29: comparison with type I interferons.

Authors:  Anthony Meager; Kumuthini Visvalingam; Paula Dilger; Donna Bryan; Meenu Wadhwa
Journal:  Cytokine       Date:  2005-07-21       Impact factor: 3.861

6.  Interferon-lambda (IFN-λ) induces signal transduction and gene expression in human hepatocytes, but not in lymphocytes or monocytes.

Authors:  Harold Dickensheets; Faruk Sheikh; Ogyi Park; Bin Gao; Raymond P Donnelly
Journal:  J Leukoc Biol       Date:  2012-12-20       Impact factor: 4.962

7.  Analysis of IL28B variants in an Egyptian population defines the 20 kilobases minimal region involved in spontaneous clearance of hepatitis C virus.

Authors:  Vincent Pedergnana; Mohamed Abdel-Hamid; Julien Guergnon; Amira Mohsen; Lénaïg Le Fouler; Ioannis Theodorou; Mostafa Kamal Mohamed; Arnaud Fontanet; Sabine Plancoulaine; Laurent Abel
Journal:  PLoS One       Date:  2012-06-14       Impact factor: 3.240

8.  Deciphering the interleukin 28B variants that better predict response to pegylated interferon-α and ribavirin therapy in HCV/HIV-1 coinfected patients.

Authors:  Montserrat de Castellarnau; Ester Aparicio; Mariona Parera; Sandra Franco; Cristina Tural; Bonaventura Clotet; Miguel Angel Martínez
Journal:  PLoS One       Date:  2012-02-06       Impact factor: 3.240

Review 9.  The interferons and their receptors--distribution and regulation.

Authors:  Nicole A de Weerd; Thao Nguyen
Journal:  Immunol Cell Biol       Date:  2012-03-13       Impact factor: 5.126

10.  IL28B expression depends on a novel TT/-G polymorphism which improves HCV clearance prediction.

Authors:  Stéphanie Bibert; Thierry Roger; Thierry Calandra; Murielle Bochud; Andreas Cerny; Nasser Semmo; François H T Duong; Tilman Gerlach; Raffaele Malinverni; Darius Moradpour; Francesco Negro; Beat Müllhaupt; Pierre-Yves Bochud
Journal:  J Exp Med       Date:  2013-05-27       Impact factor: 14.307

View more
  64 in total

Review 1.  Type-I-interferons in infection and cancer: Unanticipated dynamics with therapeutic implications.

Authors:  Martina Musella; Gwenola Manic; Ruggero De Maria; Ilio Vitale; Antonella Sistigu
Journal:  Oncoimmunology       Date:  2017-04-05       Impact factor: 8.110

2.  Interferon-λ restricts West Nile virus neuroinvasion by tightening the blood-brain barrier.

Authors:  Helen M Lazear; Brian P Daniels; Amelia K Pinto; Albert C Huang; Sarah C Vick; Sean E Doyle; Michael Gale; Robyn S Klein; Michael S Diamond
Journal:  Sci Transl Med       Date:  2015-04-22       Impact factor: 17.956

3.  Respiratory syncytial virus infection induces a subset of types I and III interferons in human dendritic cells.

Authors:  Philippa Hillyer; Viraj P Mane; Aaron Chen; Maria B Dos Santos; Lynnsie M Schramm; Rachel E Shepard; Cindy Luongo; Cyril Le Nouën; Lei Huang; Lihan Yan; Ursula J Buchholz; Ronald G Jubin; Peter L Collins; Ronald L Rabin
Journal:  Virology       Date:  2017-01-31       Impact factor: 3.616

4.  Interferon λ 3 and 4 Genotyping Using High-Resolution Melt Curve Analysis Suitable for Multiple Clinical Sample Types.

Authors:  François M J Lamoury; Sofia Bartlett; Brendan Jacka; Behzad Hajarizadeh; Jason Grebely; Gail V Matthews; Gregory J Dore; Tanya L Applegate
Journal:  J Mol Diagn       Date:  2015-07-04       Impact factor: 5.568

5.  Comparison of functional variants in IFNL4 and IFNL3 for association with HCV clearance.

Authors:  Thomas R O'Brien; Ruth M Pfeiffer; Ashley Paquin; Krystle A Lang Kuhs; Sabrina Chen; Herbert L Bonkovsky; Brian R Edlin; Charles D Howell; Gregory D Kirk; Mark H Kuniholm; Timothy R Morgan; Howard D Strickler; David L Thomas; Ludmila Prokunina-Olsson
Journal:  J Hepatol       Date:  2015-07-15       Impact factor: 25.083

6.  Explaining Pathogenicity of Congenital Zika and Guillain-Barré Syndromes: Does Dysregulation of RNA Editing Play a Role?

Authors:  Helen Piontkivska; Noel-Marie Plonski; Michael M Miyamoto; Marta L Wayne
Journal:  Bioessays       Date:  2019-05-20       Impact factor: 4.345

7.  Association of Single-Nucleotide Polymorphisms in IL28B, but Not TNF-α, With Severity of Disease Caused by Andes Virus.

Authors:  Jenniffer Angulo; Karla Pino; Natalia Echeverría-Chagas; Claudia Marco; Constanza Martínez-Valdebenito; Héctor Galeno; Eliecer Villagra; Lilian Vera; Natalia Lagos; Natalia Becerra; Judith Mora; Andrea Bermúdez; Marcela Cárcamo; Janepsy Díaz; Juan Francisco Miquel; Marcela Ferrés; Marcelo López-Lastra
Journal:  Clin Infect Dis       Date:  2015-09-22       Impact factor: 9.079

8.  Genetic Variation at IFNL4 Influences Extrahepatic Interferon-Stimulated Gene Expression in Chronic HCV Patients.

Authors:  Brad R Rosenberg; Catherine A Freije; Naoko Imanaka; Spencer T Chen; Jennifer L Eitson; Rachel Caron; Skyler A Uhl; Marija Zeremski; Andrew Talal; Ira M Jacobson; Charles M Rice; John W Schoggins
Journal:  J Infect Dis       Date:  2018-01-30       Impact factor: 5.226

9.  Hepatic IFN-Induced Protein with Tetratricopeptide Repeats Regulation of HCV Infection.

Authors:  Yuji Ishida; Masakazu Kakuni; Bo-Ram Bang; Go Sugahara; Daryl T-Y Lau; Chise Tateno-Mukaidani; Meng Li; Michael Gale; Takeshi Saito
Journal:  J Interferon Cytokine Res       Date:  2019-03       Impact factor: 2.607

Review 10.  Human Genetic Determinants of Viral Diseases.

Authors:  Adam D Kenney; James A Dowdle; Leonia Bozzacco; Temet M McMichael; Corine St Gelais; Amanda R Panfil; Yan Sun; Larry S Schlesinger; Matthew Z Anderson; Patrick L Green; Carolina B López; Brad R Rosenberg; Li Wu; Jacob S Yount
Journal:  Annu Rev Genet       Date:  2017-08-30       Impact factor: 16.830

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.